Mercado de ensayo y secuenciación de miARN: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00006960
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 156
Buy Now

Se espera que el mercado de ensayos y secuenciación de miARN alcance los 468,99 millones de dólares en 2027, desde los 192,31 millones de dólares de 2019; se estima que crecerá a una tasa compuesta anual del 11,9 % entre 2020 y 2027.

El miARN es una pequeña molécula de ARN no codificante de 20 a 30 nucleótidos de longitud, y Desempeña un papel importante en la regulación genética. Como es parcialmente complementario al ARN mensajero (ARNm), cumple una función importante de regular negativamente la expresión genética, lo que lo convierte en un controlador clave de importantes funciones celulares. Los miARN están asociados con procesos patológicos como infecciones virales, enfermedades autoinmunes y carcinogénesis. Por ello, se están realizando extensas investigaciones para identificar nuevos miARN. El crecimiento del mercado de ensayos y secuenciación de miARN se atribuye principalmente a factores como la ampliación de la gama de aplicaciones de miARN y el aumento de la financiación para la investigación genómica. Sin embargo, se prevé que los desafíos relacionados con la administración, la eficacia y la especificidad de las terapias basadas en miARN disuadan el crecimiento del mercado.

regiones lucrativas para el mercado de ensayos y secuenciación de miARN

Perspectivas del mercado

Ampliación de la gama de aplicaciones de microARN

Los miARN son un grupo de moléculas de ARN pequeñas y no codificantes de 20 a 30 nucleótidos. longitud. Estas moléculas se unen a un ARN mensajero (ARNm) objetivo y provocan el silenciamiento de genes, controlando así la expresión genética. Por tanto, desempeñan un papel fundamental en la fisiología y el desarrollo celular. Los miARN regulan todas las funciones celulares, como la proliferación, diferenciación y apoptosis celular. Al estar involucrados en el proceso de diferenciación, desempeñan un papel crucial a la hora de ofrecer identidad al tejido. Por lo tanto, se cree que los miARN son un marcador útil para identificar tipos de células.

Además, los miARN también están asociados con procesos patológicos como infecciones virales, enfermedades autoinmunes y carcinogénesis. Algunos de ellos pueden actuar como oncogenes (oncomiR), mientras que otros actúan como miRNA supresores de tumores. La expresión alterada de los miARN se correlaciona con la aparición de diferentes tipos de cáncer. Se está explorando el potencial de los miARN, combinados con tecnologías de secuenciación de próxima generación, como una nueva clase de biomarcadores del cáncer. Se prevé que desempeñarán un papel vital en la evaluación del desarrollo, la progresión, el pronóstico, el diagnóstico y el tratamiento del cáncer. Además, varias clases de miARN también han surgido como biomarcadores prometedores para enfermedades infecciosas causadas por patógenos, incluidos el VIH, el virus Hendra, la tuberculosis y la malaria.

Además, se han descubierto descubrimientos sobre el papel de los miARN en el desarrollo de enfermedades. Los miARN son un objetivo clave de nuevos enfoques terapéuticos. Varias terapias dirigidas a miARN contra enfermedades como el cáncer y la hepatitis han alcanzado la fase clínica. Por ejemplo, Santaris Pharma ha desarrollado una molécula terapéutica llamada Miravirsen que se dirige a miR-122 para el tratamiento de la infección por el virus de la hepatitis C (VHC); la molécula se encuentra en el ensayo clínico de Fase II. Por lo tanto, la creciente gama de aplicaciones de miARN está impulsando el crecimiento del mercado de ensayos y secuenciación de miARN.

Información basada en productos

El mercado de ensayos y secuenciación de miARN, por producto, es segmentado en preparación de biblioteca y consumibles. El segmento de consumibles tuvo una mayor participación del mercado en 2019, mientras que se prevé que el segmento de preparación de bibliotecas registre una CAGR más alta en el mercado durante el período de pronóstico.

miARN Mercado de secuenciación y ensayo, por producto: 2019 y 2027

Información basada en tecnología

Basado en la tecnología, el mercado de ensayos y secuenciación de miARN se segmenta en secuenciación por síntesis, nanoporos y semiconductores de iones. secuenciación. El segmento de secuenciación por síntesis tuvo la mayor participación de mercado en 2019; sin embargo, se espera que el segmento de nanoporos registre la CAGR más alta del mercado durante 2020-2027.

Información basada en el usuario final

Basado en Para el usuario final, el mercado de ensayos y secuenciación de miARN está segmentado en institutos de investigación, academia y CRO. El segmento de institutos de investigación tuvo la mayor participación de mercado en 2019 y se estima que registrará la CAGR más alta del mercado durante 2020-2027.


Información estratégica

La colaboración es una de las principales estrategias adoptadas por los actores del mercado de ensayos y secuenciación de miARN para ampliar la base de clientes en todo el mundo, lo que también les permite mantener su marca a nivel mundial.

Secuenciación y Mercado de ensayos: por producto

  • Preparación de biblioteca
  • Consumibles

Mercado de ensayo y secuenciación de miARN: ndash; por tecnología

  • Secuenciación por síntesis
  • Nanoporo
  • Secuenciación de semiconductores de iones

Mercado de ensayo y secuenciación de miARN &ndash ; por usuario final

  • Instituto de investigación
  • Academia
  • CRO

Mercado de ensayo y secuenciación de miARN: por Geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de Oriente Medio y África
  • Sur y Centroamérica
    • Brasil
    • Argentina
    • Resto de Sudamérica y Centroamérica

  ;

Perfiles de empresas

  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen
  • Perkin Elmer Inc.
  • Takara Bio Inc.
  • New England Biolabs
  • NorgenBiotek Corp
  • TriLinkBioTechnologies Inc
  • Lexogen GmbH
  • Tecnologías de nanoporos de Oxford
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is miRNA?

miRNA is a small non-coding RNA molecule of 20–30-nucleotide length, and it plays an important role in gene regulation. As it is partially complementary to messenger RNA (mRNA), it serves a major function of down-regulating the gene expression, which makes it a key controller of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs.

What are the driving factors for the miRNA sequencing and assay market across the globe?

The growth of the miRNA sequencing and assay market is mainly attributed to the factors such widening range of miRNA applications and rise in funding for genomics research. However, challenges related to delivery, efficacy, and specificity of miRNA-based therapeutics is projected to deter the market growth.

Who are the major players in the miRNA sequencing and assay market?

The GMP cytokines market majorly consists of the players such as Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Perkin Elmer, Inc., Takara Bio Inc., New England Biolabs, Norgen Biotek Corp, TriLink BioTechnologies Inc, Lexogen GmbH, and Oxford Nanopore Technologies among others.

The List of Companies - MiRNA Sequencing And Assay Market

  1. Illumina Inc.
  2. Thermo Fisher Scientific Inc.
  3. Qiagen
  4. Perkin Elmer Inc.
  5. Takara Bio Inc.
  6. New England Biolabs
  7. NorgenBiotek Corp
  8. TriLinkBioTechnologies Inc
  9. Lexogen GmbH
  10. Oxford Nanopore Technologies

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports